Hydrogen Solution Linked to Reduced Liver Damage in Rat Transplants
Hydrogen-rich solution attenuates cold ischemia-reperfusion injury in rat liver transplantation
Research hubs: Digestive System
This research was done in animals. Results in animals often don't carry over to people.
- Evidence type
- Animal study (rat)
- Authors
- Keiichi Uto, Seisuke Sakamoto, Weitao Que, Keita Shimata, Shintaro Hashimoto, Masataka Sakisaka, Yasuko Narita, Daiki Yoshii, Lin Zhong, Yoshihiro Komohara, Xiao-Kang Li, Yukihiro Inomata, Taizo Hibi
- Journal
- BMC Gastroenterology
- Year
- 2019
- PMID
- 30736744
- Study Type
- Rat
- Participants
- 12
- Delivery
- Solution (Dissolved)
- Dose
- Hydrogen-rich water bath for graft preservation in University of Wisconsin solution
- Outcome
- Positive
- Peer Reviewed
- Yes
- Cited by
- 36 (OpenAlex, as of November 2026)
- Country
- Japan
TL;DR
Soaking liver transplants in hydrogen-rich water before surgery can protect them from damage when blood supply is returned.
Key Finding
Liver grafts preserved in hydrogen-rich solution showed significantly reduced damage markers and better protection against ischemia-reperfusion injury (damage from lack of blood flow followed by restoration) compared to standard preservation methods in rat transplant models.
Summary
Researchers tested whether hydrogen-rich solution could protect liver grafts (transplanted organs) from damage during the storage and transplant process in rats. They preserved rat livers in a special solution containing dissolved hydrogen and found that livers stored this way had less damage, lower enzyme levels indicating injury, and better protection against cell death compared to livers stored in regular solution.
Practical Takeaway
While this rat study suggests hydrogen-rich preservation solutions may help protect transplanted livers from damage, this is early-stage research conducted only in animals. It does not yet demonstrate benefits in human transplant recipients, and much more research would be needed before this approach could be applied clinically.
Abstract (excerpt)
Background: Liver transplantation (LT) is considered the standard treatment for end-stage liver disease, but ideal donors remain in limited supply, resulting in an unavoidable increase in the need to use grafts from marginal donors. The attenuation of ischemia-reperfusion injury (IRI) in such…